Financials

  • Market Capitalization 7.56 M
  • Employee 38
  • Founded 2014
  • CEO N/A
  • Website www.longeveron.com
  • Headquarter Delaware, United States
  • FIGI BBG00YZ6JHT4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.04
Rapporto prezzo/fatturato
7 417.63

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4744
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.35 USD-1.47%+2.29%-7.60%-45.80%7.82 M USD
4751
SNGX
Soligenix, Inc. - Common Stock
0.35 USD0.00%-5.41%-2.78%-69.03%7.62 M USD
4755
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.76 USD-1.04%+1.28%+14.42%+535.09%7.46 M USD
4756
SKYE
Skye Bioscience, Inc. - Common Stock
1.68 USD+1.82%+2.44%-23.64%+110.00%7.44 M USD

Notizie